This challenge targets the hypothesis: **ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE Peroxidation** **Hypothesis Summary:** ## Mechanistic Overview ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE Peroxidation starts from the claim that modulating ALOX15 within the disease context of Alzheimer's Disease can redirect a disease-relevant process. The original description reads: "## Mechanistic Overview ALOX15-Driven Enzymatic Ferroptosis in AD Oligodendrocytes via PUFA-PE Peroxidation starts from the claim that modulating ALOX15 within the disease context of Alzheimer's Disease can redirect a disea **Falsifiable Predictions:** 1. Pharmacological modulation of ALOX15 will alter Alzheimer's Disease markers in validated models by ≥20% 2. Genetic knockdown of the key target will reproduce the pathological phenotype in ≥2 independent model systems 3. Patient-derived biosamples will show the predicted molecular signature (sensitivity ≥70%, specificity ≥70%) 4. Mechanistic intervention at the proposed node will rescue neuronal viability in vitro by ≥30% **Bounty Tier:** $127,214 USD (composite score 0.772) **Challenge Type:** Open — any team may submit experimental evidence supporting or refuting this hypothesis **Success Criteria:** Peer-reviewed evidence demonstrating mechanistic validation of ≥2 of the 4 predictions, with independent replication.